This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Neurotech Pharmaceuticals Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovator Spotlight: Jin-Hwan Lee - Revolutionizing Pharmaceutical Composition in Seongnam-si
Introduction:
Jin-Hwan Lee, a talented inventor based in Seongnam-si, KR, is making waves in the pharmaceutical industry with his groundbreaking patents. With a total of 2 patents under his belt, Lee is spearheading innovative solutions for treating and preventing degenerative and inflammatory diseases.
Latest Patents:
Lee's latest patent showcases a pharmaceutical composition designed to combat inflammatory diseases and cell damage. This groundbreaking invention utilizes a 2-hydroxybenzoic acid derivative to effectively treat conditions such as gastritis, arthritis, diabetes, Alzheimer's disease, and more. His commitment to advancing medical treatments is evident in the scope of diseases addressed by his innovative composition.
Career Highlights:
Currently employed at Neurotech Pharmaceuticals Co., Ltd., Lee is instrumental in driving forward cutting-edge solutions in the field of pharmaceuticals. His dedication to research and development has led to the successful creation of impactful patents that have the potential to revolutionize healthcare as we know it.
Collaborations:
In his pursuit of excellence, Lee collaborates closely with esteemed colleagues Byoung-Joo Gwag and Sung-Ig Cho at Neurotech Pharmaceuticals Co., Ltd. Together, they form a dynamic team driving innovation and pushing the boundaries of medical advancements.
Conclusion:
Jin-Hwan Lee's passion for advancing pharmaceutical compositions and his dedication to improving healthcare outcomes exemplify the spirit of innovation. Through his patented inventions and collaborations with industry experts, Lee is shaping the future of medical treatment and setting new standards for excellence in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile